Name | (3-bromophenyl)-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone |
---|---|
Synonyms |
UNC 926 hydrochloride
UNC-926 |
Description | UNC-926 is a methyl-lysine (Kme) reader domain inhibitor; inhibits L3MBTL1 with an IC50 of 3.9 μM. |
---|---|
Related Catalog | |
Target |
IC50: 3.9 μM (L3MBTL1)[1] |
In Vitro | UNC-926 inhibits L3MBTL1 with an IC50 of 3.9 μM. L3MBTL1UNC-926 also exhibits a low micromolar affinity for the close homolog, L3MBTL3, with a decrease in affinity for the other MBT domains and no binding to CBX7. UNC-926 inhibits binding of the 3xMBT domain to H4K20me1. It selectively inhibits the L3MBTL13xMBT-H4K20me1 interaction in a dose-dependent manner. UNC-926 does not have an effect on the binding of 53BP1 to H4K20me1, demonstrating specificity of UNC-926 for L3MBTL1 over 53BP1[1]. |
References |
Molecular Formula | C16H21BrN2O |
---|---|
Molecular Weight | 337.25500 |
Exact Mass | 336.08400 |
PSA | 23.55000 |
LogP | 3.02530 |
Storage condition | -20℃ |
RIDADR | NONH for all modes of transport |
---|